Secondaries announced 4.27.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.

Company: Ignyta, Inc.
Symbol: RXDX
Price: Last trade $7.38
Trade Date: 4/29
Shares: 6.8 million
Underwriter(s) J.P. Morgan, Piper Jaffray
Rating=Subscription Needed

Company: Theravance
Symbol: TBPH
Price: Last trade $23.57
Trade Date: 4/29
Shares: 4.2 million
Underwriter(s) Leerink, Evercore ISI
Rating=Subscription Needed

Company: ADMA Biologics, Inc.
Symbol: ADMA
Price: Last trade $7.63
Trade Date: 4/28
Shares: 1.6 million
Underwriter(s) Raymond James
Rating=Subscription Needed